ArticlePloS one2021

Chronic peptide-based GIP receptor inhibition exhibits modest glucose metabolic changes in mice when administered either alone or combined with GLP-1 agonism.

Jason A West et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.